Kun Li
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 5%
- Microbial Metabolic Engineering and Bioproduction
- Enzyme Catalysis and Immobilization
- RNA modifications and cancer
- RNA Research and Splicing
Papers in
-
- RNA modifications and cancer 12
- RNA Research and Splicing 10
- Microbial Metabolic Engineering and Bioproduction 9
- Circular RNAs in diseases 8
- Enzyme Catalysis and Immobilization 7
-
- Cancer-related molecular mechanisms research 20
- MicroRNA in disease regulation 8
- Co-authors
- Ziqiang Wang (16 shared papers)Ping Xu (11 shared papers)Cuiqing Ma (11 shared papers)Chao Gao (9 shared papers)Lixiang Li (8 shared papers)Lijie Zhang (5 shared papers)Yu Wang (5 shared papers)Chao Chen (3 shared papers)
- Journals
- Frontiers in Immunology (3 papers)Frontiers in Oncology (3 papers)Metabolic Engineering (2 papers)Green Chemistry (2 papers)Frontiers in Genetics (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Kun Li
118 papers receiving 2.3k citations
Kun Li's Hit Papers
Peers
Comparison fields: 5 of 122
- Cancer Research 407
- Molecular Biology 1.3k
- Biomedical Engineering 537
- Radiology, Nuclear Medicine and Imaging 236
- Immunology 140
Countries citing papers authored by Kun Li
This map shows the geographic impact of Kun Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kun Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kun Li more than expected).
Fields of papers citing papers by Kun Li
This network shows the impact of papers produced by Kun Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kun Li. The network helps show where Kun Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Kun Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 129 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 132 | |
| 2 | 2014 | 118 | |
| 3 | 2013 | 96 | |
| 4 | lncRNA NEAT1: Key player in neurodegenerative diseases Hit paper breakdown → | 2023 | 92 |
| 5 | 2019 | 91 | |
| 6 | 2021 | 77 | |
| 7 | 2016 | 72 | |
| 8 | 2021 | 66 | |
| 9 | 2014 | 62 | |
| 10 | 2021 | 53 | |
| 11 | 2014 | 50 | |
| 12 | 2014 | 48 | |
| 13 | 2009 | 47 | |
| 14 | 2019 | 45 | |
| 15 | 2013 | 40 | |
| 16 | 2010 | 35 | |
| 17 | 2021 | 35 | |
| 18 | 2020 | 32 | |
| 19 | 2020 | 31 | |
| 20 | 2022 | 29 |
About Kun Li
Kun Li is a scholar working on Molecular Biology, Cancer Research, Radiology, Nuclear Medicine and Imaging, Oncology and Biomedical Engineering, having authored 129 papers that have together received 2.3k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (20 papers), RNA modifications and cancer (12 papers), RNA Research and Splicing (10 papers), Laser Applications in Dentistry and Medicine (9 papers), Microbial Metabolic Engineering and Bioproduction (9 papers), MicroRNA in disease regulation (8 papers), Circular RNAs in diseases (8 papers) and Enzyme Catalysis and Immobilization (7 papers). The work is most often cited by research in Cancer Research (407 citations), Molecular Biology (1.3k citations), Biomedical Engineering (537 citations), Radiology, Nuclear Medicine and Imaging (236 citations) and Immunology (140 citations). Kun Li has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Ziqiang Wang, Ping Xu, Cuiqing Ma, Chao Gao, Lixiang Li, Lijie Zhang, Yu Wang, Chao Chen, Fei Tao and Youqiang Xu. Their work appears in journals such as Frontiers in Immunology, Frontiers in Oncology, Metabolic Engineering, Green Chemistry and Frontiers in Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.